Ethyl 3-amino-4-(4-benzyl-1-piperazinyl)benzoate, identified by its CAS number 792946-69-1, is a chemical compound characterized by its complex structure, which includes an ethyl ester group, an amino group, and a piperazine moiety. This compound typically exhibits properties associated with both aromatic and aliphatic systems due to its benzene ring and piperazine structure. It is likely to be a solid at room temperature, with moderate solubility in organic solvents, and may exhibit basic properties due to the presence of the amino group. The piperazine ring can contribute to its pharmacological activity, making it of interest in medicinal chemistry, particularly in the development of compounds with potential therapeutic applications. Additionally, the presence of the benzyl group may enhance lipophilicity, influencing its bioavailability and interaction with biological targets. Overall, this compound's unique structural features suggest potential utility in various chemical and pharmaceutical contexts.

ethyl 3-amino-4-(4-benzyl-1-piperazinyl)benzoate

792946-69-1: Ethyl 3-amino-4-(4-benzyl-1-piperazinyl)benzoate, identified by its CAS number 792946-69-1, is a chemical compound characterized by its complex structure, which includes an ethyl ester group, an amino group, and a piperazine moiety. This compound typically exhibits properties associated with both aromatic and aliphatic systems due to its benzene ring and piperazine structure. It is likely to be a solid at room temperature, with moderate solubility in organic solvents, and may exhibit basic properties due to the presence of the amino group. The piperazine ring can contribute to its pharmacological activity, making it of interest in medicinal chemistry, particularly in the development of compounds with potential therapeutic applications. Additionally, the presence of the benzyl group may enhance lipophilicity, influencing its bioavailability and interaction with biological targets. Overall, this compound's unique structural features suggest potential utility in various chemical and pharmaceutical contexts.

DCLX069

<p>DCLX069: PRMT1 inhibitor, IC50=17.9µM, targets SAM pocket, inhibits breast/liver cancer, and AML cell growth.</p>

CAS 792946-69-1

ethyl 3-amino-4-(4-benzyl-1-piperazinyl)benzoate

DCLX069

Ref: 54-BUP12363

DCLX069

Ref: TM-T27133